APA (7th ed.) Citation

Run-Jie Wang, Rui-Quan Ke, Yi-Feng Yu, Guan-Zhong Lu, & San-Gang Wu. (2024). Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Run-Jie Wang, Rui-Quan Ke, Yi-Feng Yu, Guan-Zhong Lu, and San-Gang Wu. Addition of Nimotuzumab to Concurrent Chemoradiotherapy After Induction Chemotherapy Improves Outcomes of Patients with Locally Advanced Nasopharyngeal Carcinoma. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Run-Jie Wang, et al. Addition of Nimotuzumab to Concurrent Chemoradiotherapy After Induction Chemotherapy Improves Outcomes of Patients with Locally Advanced Nasopharyngeal Carcinoma. Frontiers Media S.A., 2024.